№ lp_1_36589
File format: docx
Character count: 10210
File size: 1444 KB
The document is a work plan for DPO Australia, outlining their objectives and strategies for promoting the rights of people with disabilities in Australia over the specified period.
Year:
2016
Region / City:
Australia
Subject:
Disability Rights, Human Rights
Document Type:
Work Plan
Organization:
Disabled People’s Organisations Australia (DPO Australia)
Author:
Carolyn Frohmader
Target Audience:
Government, Disability Advocacy Groups, Stakeholders in Disability Rights
Period of Action:
July 2016 – June 2017
Approval Date:
June 2016
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Country:
Ireland
Type of document:
Position paper
Organization:
DPO Network
Author:
Jacqui Browne
Period covered:
2025–2030
Audience:
Policymakers, disability advocacy groups
Topic:
Co-creation, disability rights, policy development
Endorsed by:
Department of Children, Disability and Equality
References:
UN Convention on the Rights of Persons with Disabilities (UN CRPD)
Includes case studies:
Yes
Language style:
Professional, policy-oriented
Year:
2026
Region / City:
Not specified
Subject:
Data protection, GDPR compliance
Document Type:
Appointment letter
Organization / Institution:
Controller (Principal)
Author:
Not specified
Target Audience:
Employee designated as DPO
Legal Reference:
Articles 35, 36, 37, 38, 39 GDPR
Effective Date:
Date of signature
Duration:
Undefined / Until termination of employment contract
Responsibilities:
Monitoring compliance, advising on data protection, cooperating with supervisory authorities, contact point for data subjects
Compensation:
As per employment contract or additional remuneration specified
Year:
2010
Region / City:
Northern Territory, Australia
Subject:
Statutory Declaration
Document Type:
Form
Authority / Institution:
Nursing and Midwifery Board of Australia
Author:
Not specified
Target Audience:
Applicants for nursing and midwifery registration
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2016
Region / City:
Australia
Subject:
Health practitioner regulation, professional misconduct, drug use
Document Type:
Tribunal Decision
Body / Institution:
ACT Civil & Administrative Tribunal
Author:
Medical Board of Australia
Target Audience:
Health professionals, legal professionals
Period of Validity:
N/A
Date of Approval:
8 March 2016
Date of Amendments:
N/A
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2009
Country:
Australia
Jurisdiction:
National
Subject:
Recency of practice requirements in physiotherapy
Document type:
Professional practice guidelines
Issuing body:
Physiotherapy Board of Australia
Legal basis:
Health Practitioner Regulation National Law Act 2009
Target profession:
Physiotherapists
Registration categories covered:
General, specialist, provisional and limited registration
Scope of application:
Registration and renewal of registration
Related standards:
Registration Standard for Recency of Practice
Definitions source:
Australian Standards for Physiotherapy (2006)
Year:
2000-2013
Region / City:
South Australia
Topic:
Epidemiology, Ross River Virus, Public Health
Document Type:
Research Study
Organization / Institution:
South Australian Department for Health and Wellbeing, University of Adelaide
Author:
Jingwen Liu, Alana Hansen, Scott Cameron, Peng Bi
Target Audience:
Public health professionals, researchers, policymakers
Period of Validity:
2000-2013
Approval Date:
Not specified
Date of Last Update:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Certificate number:
Office use only
Form identifier:
LB1
Document type:
Health certificate
Legislation:
Biosecurity and Agriculture Management Act 2007; Biosecurity and Agriculture Management Regulations 2013
Jurisdiction:
Western Australia
Issuing authority:
Department of Primary Industries and Regional Development
Animal species:
Sheep
Purpose:
Movement of sheep into Western Australia
Consignment scope:
One or more sheep from a property moving to a destination property
Entry inspection points:
Kalgoorlie; Kununurra; Perth Airport; Quarantine facility; Other specified
Parties involved:
Exporting owner or manager; Importing owner or manager; Veterinarian or authorised government inspector
Health conditions covered:
Cattle tick; Footrot; Johne’s disease; Liver fluke
Advance notice requirement:
Copy provided to Entry Inspection Point at least three working days before arrival
Completion requirements:
Parts 1 and 2 completed by specified parties; declarations and signatures required
Source type:
Statutory administrative form establishing health and biosecurity declarations and movement conditions for livestock entering Western Australia.
Year:
2023
Region / city:
Australia
Theme:
Pharmaceutical submission
Document type:
Pharmaceutical submission
Organization / institution:
Pfizer Australia Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, nurse practitioners
Effective period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Context:
Pharmaceutical submission requesting the inclusion of a new formulation of methotrexate under the General Schedule of the PBS for Australia, with changes in packaging and excipient composition.
Year:
2023
Region / city:
Australia
Topic:
Vedolizumab submission for chronic pouchitis treatment
Document type:
Submission for listing of medicinal product
Agency:
Therapeutic Goods Administration (TGA)
Author:
Takeda Pharmaceuticals Australia Pty. Ltd.
Target audience:
Healthcare professionals, regulatory authorities
Effective period:
From 29 June 2023
Approval date:
29 June 2023
Modification date:
N/A
Year:
2022
Region / City:
Australia
Topic:
Medical treatment approval and submission for pembrolizumab and lenvatinib
Document type:
Submission for drug listing
Organization / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC), Therapeutic Goods Administration (TGA)
Author:
Merck Sharp & Dohme (Australia) Pty Ltd
Target audience:
Medical professionals, health regulators
Period of validity:
2022 onward
Approval date:
August 10, 2021
Amendment date:
Not specified
Year:
2024
Region / city:
Australia and New Zealand
Topic:
Refrigerant handling, refrigeration systems, air conditioning
Document type:
Code of Practice
Organ / institution:
AIRAH, Australian Refrigeration Council (ARC), Department of Climate Change, Energy, the Environment and Water (DCCEEW)
Author:
AIRAH, ARC, DCCEEW
Target audience:
Industry professionals, public, refrigeration and air conditioning contractors
Validity period:
Until August 19, 2024
Approval date:
2024
Amendment date:
N/A
Year:
2023
Region / city:
United Kingdom, Australia
Subject:
Preferential Tariff
Document Type:
Regulatory Document
Organization / Institution:
United Kingdom Government
Author:
Not specified
Target Audience:
Customs, Trade Professionals
Period of validity:
From 1st January 2024
Approval Date:
5th December 2023
Date of amendments:
Not specified
Year:
2023
Region / City:
Australia
Theme:
Oncology, Pharmaceutical
Document Type:
Submission
Organization / Institution:
Merck Sharp & Dohme (Australia) Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, policymakers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2018
Region / City:
Australia
Topic:
Pharmaceutical Submission, Cancer Treatment
Document Type:
Submission
Organization / Institution:
Takeda Pharmaceuticals Australia Pty Ltd
Author:
Takeda Pharmaceuticals Australia Pty Ltd
Target Audience:
Healthcare professionals, PBAC
Period of Validity:
Ongoing
Approval Date:
23 May 2018
Date of Amendments:
Not specified
Year:
2023
Month:
January
Subject area:
Diabetes foot care
Topic:
Hospital activity and amputation indicators
Document type:
Technical document
Geographic scope:
England
Institution:
National Cardiovascular Intelligence Network
Data sources:
Hospital Episode Statistics; National Diabetes Audit; Quality and Outcomes Framework
Population:
Adults aged 18 years and over
Time period covered:
Aggregated financial years 2018/19–2020/21
Methodology:
Indicator definitions and direct age standardisation
Update history:
Methodological changes since December 2021
Intended use:
Statistical reporting and profile interpretation
Contact information:
[email protected]
Code:
MM06100
Level:
11 (E)
Generic Function:
Mission Specialized Activity Manager
Job Family:
Medical and Paramedical
Reports to (Hierarchical):
Medical Coordinator
Reports to (Functional):
Medical Coordinator
Organization:
Médecins Sans Frontières (MSF)
Main Purpose:
Coordination and supervision of mission-level medical or paramedical activities
Scope of Activities:
Mental health, patient support, health promotion and related areas
Key Responsibilities:
Coordination, monitoring, evaluation, strategy development, technical supervision, data analysis and representation
Education Requirement:
Related university degree in psychology, counseling, social sciences, communication, health promotion or educational sciences
Experience Requirement:
Minimum two years in related roles and at least one year with MSF as an activity manager
Language Requirements:
Essential mission language; local language desirable
Technical Skills:
Computer literacy in word processing, spreadsheets and internet use
Competencies:
People management, commitment to MSF principles, behavioural flexibility, results and quality orientation, teamwork and cooperation
Document Type:
Job description
Sector:
Humanitarian medical assistance
Target Audience:
MSF staff and candidates for mission-level medical management roles
Year:
2013
Region / City:
Long Beach, CA
Topic:
Maintenance and repair of medical equipment
Document Type:
Cooperative Agreement
Agency:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Contractors, healthcare system providers
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified